FMR LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
FMR LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$115,780,231
+19.2%
4,308,903
+58.2%
0.01%
+25.0%
Q2 2023$97,154,885
+39.3%
2,724,478
-0.8%
0.01%
+166.7%
Q1 2023$69,760,928
-13.6%
2,746,494
+38.0%
0.00%
-62.5%
Q4 2022$80,695,459
-0.3%
1,989,533
-18.8%
0.01%0.0%
Q3 2022$80,964,000
-16.2%
2,449,726
-10.7%
0.01%
-20.0%
Q2 2022$96,580,000
+50.2%
2,742,968
+96.1%
0.01%
+100.0%
Q1 2022$64,318,000
-29.0%
1,398,524
+2.4%
0.01%
-28.6%
Q4 2021$90,591,000
+9.0%
1,366,377
+2.6%
0.01%0.0%
Q3 2021$83,102,000
-21.8%
1,331,123
+3.7%
0.01%
-12.5%
Q2 2021$106,335,000
+22.2%
1,283,929
-2.1%
0.01%
+14.3%
Q1 2021$87,002,000
-20.1%
1,312,051
-7.6%
0.01%
-30.0%
Q4 2020$108,947,000
+33.6%
1,419,876
-25.0%
0.01%
+25.0%
Q3 2020$81,521,000
-31.9%
1,893,198
-31.6%
0.01%
-38.5%
Q2 2020$119,620,000
+46.9%
2,769,622
-2.1%
0.01%
+18.2%
Q1 2020$81,416,000
-31.8%
2,829,880
+50.4%
0.01%
-15.4%
Q4 2019$119,338,000
+212.6%
1,881,408
+38.9%
0.01%
+160.0%
Q3 2019$38,180,000
+6.3%
1,354,856
+0.0%
0.01%
+25.0%
Q2 2019$35,901,000
+14.2%
1,354,758
-20.9%
0.00%0.0%
Q1 2019$31,425,000
+46.0%
1,712,539
-1.2%
0.00%
+33.3%
Q4 2018$21,522,000
-43.2%
1,732,845
-12.4%
0.00%
-25.0%
Q3 2018$37,922,0001,978,2180.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders